skip nav
  Home | About CDC | Press Room | A-Z Index | Contact Us
spacer
CDC Centers for Disease Control and Prevention Home Page
CDC en Español
Search:  
CDC Home > HIV/AIDSTopics > Statistics and Surveillance > Reports > Cases of HIV Infection and AIDS in the United States, by Race/Ethnicity, 1998–2002
spacer
spacer spacer
spacer
 
Skip Nav spacer
spacer
Table 12. Reported cases of HIV/AIDS for female adults and adolescents, by race/ethnicity and exposure category,1999–2002—30 areas with confidential name-based HIV infection reporting
spacer
spacer
View PDF PDF icon

  Year of diagnosis
Exposure category 1999 2000 2001 2002
 
White, not Hispanic
Injection drug use 405 360 338 249
Hemophilia/coagulation disorder 2 1 1 0
Heterosexual contact 813 687 686 587
Sex with injection drug user 243 174 191 146
Sex with bisexual male 80 55 56 48
Sex with person with hemophilia 8 9 7 7
Sex with HIV-infected transfusion recipient 6 7 4 8
Sex with HIV-infected person, risk not specified 476 442 428 378
Receipt of blood transfusion, blood components, or tissue 23 15 11 6
Other/risk not reported or identifieda 441 467 489 678
Total 1,684 1,530 1,525 1,520
 
Black, not Hispanic
Injection drug use 750 612 516 382
Hemophilia/coagulation disorder 3 7 2 2
Heterosexual contact 2,928 2,707 2,493 2,059
Sex with injection drug user 497 457 358 295
Sex with bisexual male 157 132 127 111
Sex with person with hemophilia 8 10 3 6
Sex with HIV-infected transfusion recipient 11 7 12 10
Sex with HIV-infected person, risk not specified 2,255 2,101 1,993 1,637
Receipt of blood transfusion, blood components, or tissue 53 48 40 33
Other/risk not reported or identifieda 2,323 2,222 2,292 2,931
Total 6,057 5,596 5,343 5,407
 
Hispanic
Injection drug use 103 83 93 64
Hemophilia/coagulation disorder 0 0 0 0
Heterosexual contact 358 310 361 309
Sex with injection drug user 91 72 85 62
Sex with bisexual male 17 22 18 17
Sex with person with hemophilia 0 0 0 1
Sex with HIV-infected transfusion recipient 3 0 2 4
Sex with HIV-infected person, risk not specified 247 216 256 225
Receipt of blood transfusion, blood components, or tissue 7 8 6 5
Other/risk not reported or identifieda 182 202 221 312
Total 650 603 681 690
 
Asian/Pacific Islander
Injection drug use 2 2 0 0
Hemophilia/coagulation disorder 0 0 0 0
Heterosexual contact 13 19 15 16
Sex with injection drug user 2 1 1 0
Sex with bisexual male 0 2 1 1
Sex with person with hemophilia 0 0 0 0
Sex with HIV-infected transfusion recipient 0 0 2 0
Sex with HIV-infected person, risk not specified 11 16 11 15
Receipt of blood transfusion, blood components, or tissue 0 1 2 0
Other/risk not reported or identifieda 17 17 16 21
Total 32 39 33 37
 
American Indian/Alaska Native
Injection drug use 10 12 8 12
Hemophilia/coagulation disorder 0 0 0 0
Heterosexual contact 21 28 11 23
Sex with injection drug user 5 12 6 5
Sex with bisexual male 0 5 0 2
Sex with person with hemophilia 1 1 0 0
Sex with HIV-infected transfusion recipient 2 0 0 0
Sex with HIV-infected person, risk not specified 13 10 5 16
Receipt of blood transfusion, blood components, or tissue 1 1 0 2
Other/risk not reported or identifieda 9 8 11 10
Total 41 49 30 47
Total casesb 8,496 7,872 7,687 7,706
Data include male adults and adolescents with a diagnosis of HIV infection. This includes male adults and adolescents with a diagnosis of HIV infection (not AIDS), a diagnosis of HIV infection and a later AIDS diagnosis, and concurrent diagnoses of HIV infection and AIDS.
Since 1998, the following 30 areas have had laws or regulations requiring confidential name-based HIV infection reporting: Alabama, Arkansas, Arizona, Florida, Colorado, Iowa, Idaho, Indiana, Louisiana, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New Jersey, New Mexico, Nevada, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Utah, Virginia, Wisconsin, West Virginia, Wyoming, and the U.S. Virgin Islands. Since July 1997, Florida has had confidential name-based HIV infection reporting only for new diagnoses.
a Includes hemophilia, blood transfusion, perinatal, and risk not reported or not identified.
b Includes female adults and adolescents of unknown race or multiple races.
Last Modified: June 14, 2006
Last Reviewed: June 14, 2006
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
spacer
spacer
spacer
spacer
  Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
spacer
spacer
spacer Safer, Healthier People
spacer
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov.
spacer USA.gov: The U.S. Government's Official Web PortalDHHS Department of Health
and Human Services